(Q34706981)

4 August 2017

1 reference

title

Novel therapies in the treatment of spondyloarthritis (English)

1 reference

4 August 2017

Walter P Maksymowych

1

1 reference

4 August 2017

language of work or name

English

0 references

publication date

1 July 2002

1 reference

Expert Opinion on Investigational Drugs

4 August 2017

published in

1 reference

4 August 2017

volume

11

1 reference

4 August 2017

issue

7

1 reference

4 August 2017

page(s)

937-946

1 reference

Comparative study of the synovial histology in rheumatoid arthritis, spondyloarthropathy, and osteoarthritis: influence of disease duration and activity

4 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1517%2F13543784.11.7.937

Functional disability predicts total costs in patients with ankylosing spondylitis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.11.7.937

Immunohistological study of entheses in spondyloarthropathies: comparison in rheumatoid arthritis and osteoarthritis

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.11.7.937

Recurrence risk modelling of the genetic susceptibility to ankylosing spondylitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.11.7.937

Spontaneous inflammatory disease in transgenic rats expressing HLA-B27 and human beta 2m: an animal model of HLA-B27-associated human disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.11.7.937

Use of immunohistologic and in situ hybridization techniques in the examination of sacroiliac joint biopsy specimens from patients with ankylosing spondylitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.11.7.937

Efficacy of celecoxib, a cyclooxygenase 2-specific inhibitor, in the treatment of ankylosing spondylitis: a six-week controlled study with comparison against placebo and against a conventional nonsteroidal antiinflammatory drug

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.11.7.937

Comparison of sulfasalazine and placebo in the treatment of ankylosing spondylitis. A Department of Veterans Affairs Cooperative Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.11.7.937

Benign and malignant musculoskeletal lesions: dynamic contrast-enhanced MR imaging--parametric "first-pass" images depict tissue vascularization and perfusion.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.11.7.937

Low T cell production of TNFalpha and IFNgamma in ankylosing spondylitis: its relation to HLA-B27 and influence of the TNF-308 gene polymorphism

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.11.7.937

Effects of a loading dose regimen of three infusions of chimeric monoclonal antibody to tumour necrosis factor alpha (infliximab) in spondyloarthropathy: an open pilot study

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.11.7.937

Randomized double-blind comparison of chimeric monoclonal antibody to tumor necrosis factor alpha (infliximab) versus placebo in active spondylarthropathy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.11.7.937

Successful treatment of active ankylosing spondylitis with the anti-tumor necrosis factor alpha monoclonal antibody infliximab

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.11.7.937

Studies on the chronic phase of adjuvant arthritis: effect of SR 41319, a new diphosphonate

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.11.7.937

A six-month randomized, controlled, double-blind, dose-response comparison of intravenous pamidronate (60 mg versus 10 mg) in the treatment of nonsteroidal antiinflammatory drug-refractory ankylosing spondylitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.11.7.937

10.1517/13543784.11.7.937

21 January 2018

Identifiers

DOI

1 reference

4 August 2017

1 reference